Target Name: OR10X1
NCBI ID: G128367
Review Report on OR10X1 Target / Biomarker Content of Review Report on OR10X1 Target / Biomarker
OR10X1
Other Name(s): olfactory receptor, family 10, subfamily X, member 1 pseudogene | Olfactory receptor family 10 subfamily X member 1 | OR1-14 | Olfactory receptor 10X1 | OR10X1P | olfactory receptor family 10 subfamily X member 1 | olfactory receptor OR1-13 pseudogene | olfactory receptor OR1-14 | OR1-13 | O10X1_HUMAN | Olfactory receptor OR1-14 | olfactory receptor 10X1

OR10X1: Potential Drug Target and Biomarker for Various Diseases

OR10X1 (Olfactory Receptor, Family 10, Subfamily X, Member 1) is a protein that is expressed in the olfactory system of the human body. It plays a crucial role in the sense of smell and is responsible for transmitting the sense of smell from the sensory system to the brain. OR10X1 has been identified as a potential drug target and is currently being studied as a potential biomarker for various diseases, including cancer.

OR10X1 is a member of the Olfactory Receptor family, which is a large gene family that is responsible for the sense of smell. The Olfactory Receptor family consists of over 200 genes that are involved in the sense of smell. OR10X1 is a pseudogene, which means that it is a genetic copy of a gene that does not code for a functional protein.

OR10X1 is expressed in the olfactory system of the human body and is involved in the production of the Olfactory Membrane Chloride (OMC), which is a critical component of the olfactory system. The OMC is responsible for the production of the pheromone, which is the chemical that transmits the sense of smell from the sensory system to the brain.

OR10X1 has been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of OR10X1 expression are associated with poor prognosis in patients with pancreatic cancer, which is one of the most aggressive forms of cancer.

In addition to its involvement in cancer, OR10X1 has also been shown to be involved in the development of other diseases, including neurodegenerative disorders and autoimmune diseases. For example, studies have shown that OR10X1 is involved in the development of Alzheimer's disease, which is a neurodegenerative disorder that is characterized by the progressive loss of brain cells.

OR10X1 has also been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. These conditions are characterized by the immune system attacking the body's own cells, leading to inflammation and damage to the body.

Despite its involvement in a wide range of diseases, OR10X1 is not yet a well-studied gene. There are currently very few studies that have focused on its role in disease, and much of the research that has been done on OR10X1 has been done in cell culture or in animal models of disease.

In conclusion, OR10X1 is a protein that is expressed in the olfactory system of the human body and is involved in the production of the Olfactory Membrane Chloride. It has been shown to be involved in the development and progression of various diseases, including cancer and neurodegenerative disorders. Given its involvement in these conditions, OR10X1 is a potential drug target and could be used as a biomarker for disease diagnosis and treatment. Further research is needed to fully understand the role of OR10X1 in disease and to develop effective treatments.

Protein Name: Olfactory Receptor Family 10 Subfamily X Member 1

Functions: Odorant receptor

The "OR10X1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10X1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1